HIV/AIDS

RSS

Bayer claims anti-HIV quinolone carboxylic acids

April 19, 1996

Cell Genesys to evaluate new gene therapy for AIDS

April 12, 1996

DaunoXome approved as first-line treatment for KS

April 12, 1996

Expanded access for delavirdine initiated

April 12, 1996

ImmuCell arranges for clinical evaluation of CryptoGAM

April 5, 1996

DuPont Merck research into protease inhibitors

April 5, 1996

New data, new approvals for DaunoXome

April 5, 1996

New protease inhibitors from BMS

April 5, 1996

U.S. phase III trials of Remune begin

March 15, 1996

Nitazoxanide advances in phase II

March 15, 1996